71 results
Page 2 of 4
6-K
EX-99.2
rg2 wwpe9klb
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.1
feqtgxbf
4 Nov 22
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
4:57pm
6-K
EX-99.2
g72m 31j5h3c8aevvc
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.1
19pacdg
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.1
caokgr7ynhwt07yb3
23 Jun 22
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
11:21am
6-K
EX-99.1
xlhonf
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.2
hrezg5k5q
6 May 22
Current report (foreign)
5:18pm
6-K
EX-99.3
mbj5wu
11 Apr 22
Current report (foreign)
5:14pm
6-K
EX-99.1
s84biqyl13sejf9e8
24 Feb 22
Galapagos 2021 results set stage for future growth
5:19pm
6-K
EX-99.1
acekqd n7r0f
29 Nov 21
Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
6:00am
6-K
EX-99.1
9x9l5pke7ahj1v
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
6-K
EX-99.2
vkehkqfjl
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
6-K
EX-99.1
1j1tby
31 Aug 21
Galapagos announces planned retirement of CEO
3:46pm
6-K
EX-99.2
91fy shspq
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
odvgxiqr5cej 2yyxh8
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
snr4yl7g
23 Jun 21
Galapagos announces departure of CSO Piet Wigerinck later this year
6:00am
6-K
EX-99.2
zor601
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
4z7tl
11 May 21
Current report (foreign)
2:10pm